These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
556 related articles for article (PubMed ID: 15107828)
1. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus. Brabender J; Marjoram P; Salonga D; Metzger R; Schneider PM; Park JM; Schneider S; Hölscher AH; Yin J; Meltzer SJ; Danenberg KD; Danenberg PV; Lord RV Oncogene; 2004 Jun; 23(27):4780-8. PubMed ID: 15107828 [TBL] [Abstract][Full Text] [Related]
2. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma. Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218 [TBL] [Abstract][Full Text] [Related]
3. Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR. Mitas M; Almeida JS; Mikhitarian K; Gillanders WE; Lewin DN; Spyropoulos DD; Hoover L; Graham A; Glenn T; King P; Cole DJ; Hawes R; Reed CE; Hoffman BJ Clin Cancer Res; 2005 Mar; 11(6):2205-14. PubMed ID: 15788668 [TBL] [Abstract][Full Text] [Related]
4. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844 [TBL] [Abstract][Full Text] [Related]
12. Advances in gene chip technique in Barrett's metaplasia and adenocarcinoma. Wang XW; Gao HJ; Fang DC J Dig Dis; 2008 May; 9(2):68-71. PubMed ID: 18419638 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression. Doak SH; Jenkins GJ; Parry EM; Griffiths AP; Baxter JN; Parry JM Mutat Res; 2004 Mar; 547(1-2):133-44. PubMed ID: 15013707 [TBL] [Abstract][Full Text] [Related]
14. [Prediction of response to neoadjuvant chemotherapy in Barrett's carcinoma by quantitative gene expression analysis]. Langer R; Specht K; Becker K; Ewald P; Sarbia M; Busch R; Feith M; Stein HJ; Siewert JR; Höfler H Verh Dtsch Ges Pathol; 2004; 88():207-13. PubMed ID: 16892554 [TBL] [Abstract][Full Text] [Related]
15. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma. Vallböhmer D; Peters JH; Oh D; Kuramochi H; Shimizu D; Demeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; DeMeester TR; Danenberg P Surgery; 2005 Oct; 138(4):701-6; discussion 706-7. PubMed ID: 16269299 [TBL] [Abstract][Full Text] [Related]